Skip to content
OpenCapital
Get started

Bio-Rad Laboratories, Inc. BIO.B Cash Provided by (Used in) Investing Activity, Including Discontinued Operation

Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
-$407.85M-797%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
——
Revvity logo
RevvityRVTY
——
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
——
Illumina logo
IlluminaILMN
——
Zoetis logo
ZoetisZTS
——

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×—
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s cash provided by (used in) investing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s cash provided by (used in) investing activity, including discontinued operation?
Bio-Rad Laboratories, Inc. (BIO.B) reported cash provided by (used in) investing activity, including discontinued operation of -$93.2M in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
Bio-Rad Laboratories, Inc.'s cash provided by (used in) investing activity, including discontinued operation decreased by 3313.8% year-over-year, from $2.9M to -$93.2M.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s cash provided by (used in) investing activity, including discontinued operation?
Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s cash provided by (used in) investing activity, including discontinued operation has grown at a -30.2% compound annual growth rate (CAGR), from -$797.38M to -$189.7M.
What does cash provided by (used in) investing activity, including discontinued operation mean?
The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.